Journal profile · Pharmacology & Pharmacy
Pharmacological Reviews
ISSN 0031-6997 · eISSN 1521-0081 · American Society for Pharmacology and Experimental Therapeutics · UNITED STATES · Quarterly · Founded 1949
Pharmacological Reviews: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 20.98; hybrid open access; APC about USD 4,500; median 178 days to acceptance (98 articles, last 24 months); community-reported acceptance: mostly invited papers; 75 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Pharmacological Reviews is published by American Society for Pharmacology and Experimental Therapeutics and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Diverse Scientific and Economic Studies, Human auditory perception and evaluation and Educational Robotics and Engineering, together about 34.4% of its articles. Its main subfields are Cellular and Molecular Neuroscience. (generated from OpenAlex topic counts and CAS ranking data)
Pharmacological Reviews Pharmacological Reviews presents important review articles covering the broad spectrum of pharmacological research. Topics covered have included biochemical and cellular pharmacology, drug metabolism and disposition, renal pharmacology, neuropharmacology, behavioral pharmacology, clinical pharmacology, and toxicology. IUPHAR nomenclature reports are published here. ASPET The American Society for Pharmacology and Experimental Therapeutics (ASPET) is a 4,000 member scientific society whose members conduct basic and clinical pharmacological research and work for academia, government, large pharmaceutical companies, small biotech companies, and non-profit organizations. ASPET members work in a variety of different fields and include neuroscientists, toxicologists, chemical biologists, pharmacists, cardiovascular scientists, and many more. Though very diverse, our members have a common bond through their membership in ASPET. Our members' research efforts help develop new medicines and therapeutic agents to fight existing and emerging diseases. More Opens in new window
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Editor-in-chief Lynette DawsPublisher website
Editorial board by country: none in mainland China; most named United States 17, Australia 6, United Kingdom 4, Germany 4, Sweden 4 (48 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance16%
- Human auditory perception and evaluationEngineering9.5%
- Educational Robotics and EngineeringComputer Science8.9%
- Receptor Mechanisms and SignalingBiochemistry, Genetics and Molecular Biology8.3%
- Neuroscience and Neuropharmacology ResearchNeuroscience5.7%
- Ferroelectric and Negative Capacitance DevicesEngineering5.5%
- Big Data and Digital EconomyComputer Science5.5%
- Neurotransmitter Receptor Influence on BehaviorNeuroscience4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Pharmacology & Pharmacy | Zone 1 |
Top journal: yesReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Pharmacology & Pharmacy | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Pharmacology & Pharmacy | Zone 1 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 20.98LetPub ·
- Impact factor (publisher)
- 20.3Publisher website ·
- CiteScore 2026-06
- 25.9LetPub ·
- CiteScore (publisher)
- 25.9Publisher website ·
- SJR 2026-06
- 4.97LetPub ·
- SNIP 2026-06
- 4.29LetPub ·
- h-index
- 210LetPub ·
- h-index
- 354OpenAlex ·
- i10-index
- 1,428OpenAlex ·
- 2-year mean citedness
- 27.97OpenAlex ·
- Self-citation rate
- 2%LetPub ·
- Share of gold OA articles
- 34.42%LetPub ·
Volume
- Articles per year
- 92LetPub ·
Articles by year OpenAlex count · 2,355 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 49 | 32 | 94 |
| 2025 | 75 | 50 | 959 |
| 2024 | 79 | 57 | 4,624 |
| 2023 | 50 | 35 | 2,210 |
| 2022 | 54 | 44 | 4,111 |
| 2021 | 40 | 31 | 4,582 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
178 daysMedian, submission to acceptance · P25–P75 133 days – 246 days
- Acceptance to online
- median 7 days (98 articles)
- Submission to online
- median 187 days
- Sample
- 98 articles with submission and acceptance dates (159 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average acceptance (community reports)
- Mostly invited papersLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,500 / EUR 4,210 / GBP 3,600 / JPY 558,140 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- American Society for Pharmacology and Experimental Therapeutics
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 1949
- ISSN
- 0031-6997
- Electronic ISSN
- 1521-0081
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Pharmacological Reviews
What CAS zone is Pharmacological Reviews in?
In the 2025 upgraded edition of the CAS Journal Ranking, Pharmacological Reviews is in Zone 1 of Medicine, and in Zone 1 of the minor category Pharmacology & Pharmacy; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Pharmacological Reviews?
The latest impact factor listed by LetPub is 20.98; CiteScore 25.9, h-index 354.
How long does peer review take at Pharmacological Reviews?
Based on the dates recorded on 98 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 178 days (interquartile range 133–246 days); the community-reported acceptance is “Mostly invited papers”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Pharmacological Reviews based?
Of the 48 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (17), Australia (6) and United Kingdom (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Pharmacological Reviews?
According to LetPub and DOAJ records, Pharmacological Reviews is indexed in SCIE and Scopus.
Is Pharmacological Reviews open access, and what is the APC?
Pharmacological Reviews is a hybrid journal. For open-access publication: APC about USD 4,500.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .